Credit Suisse Ag Erytech Pharma S.A. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$1.03 - $1.8 $4,355 - $7,612
4,229 New
4,229 $5,000
Q1 2022

May 16, 2022
SELL
$1.36 - $2.35 $22,984 - $39,715
-16,900 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.15 - $6.21 $36,335 - $104,949
16,900 New
16,900 $40,000

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email